Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Brain Metastases and Impact on Survival in Metastatic Non-small Cell Lung Cancer by Line of Treatment

NCT06557967 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT06557967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06557967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Brain Metastases and Impact on Survival in Metastatic Non-small Cell Lung Cancer by Line of Treatment
Lead sponsor
Daiichi Sankyo
Phase
Observational
Overall status
Completed
Start date
March 1, 2024
Completion date
September 30, 2024
Enrollment
22,517 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system cancer, lung cancer, metastatic cancer, non-small cell lung cancer